tm logo
VAXCYTE
Live/Registered
REGISTERED

on 27 Feb 2024

Last Applicant/ Owned by

825 Industrial Road, Suite 300

San Carlos

CA

94070

Serial Number

97310551 filed on 14th Mar 2022

Registration Number

7317079 registered on 27th Feb 2024

in the Principal Register

Correspondent Address

Christine A. Filarski

MICHAEL BEST & FRIEDRICH LLP

444 W. LAKE STREET, SUITE 3200

CHICAGO, IL 60606

Filing Basis

1. intent to use

2. filed as use application

3. use application currently

Disclaimer

NO DATA

VAXCYTE

Vaccines; Vaccine preparations; Therapeutic vaccines The mark consists of the stylized wording "VAXCYTE" with an inverted triangle design positioned on top of the stylized letter "X". The colors black, grey, and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark.

Classification Information


Class [005]
Pharmaceutical Products


Vaccines; Vaccine preparations; Therapeutic vaccines


First Use Date in General

23rd Oct 2023

First Use Date in Commerce

23rd Oct 2023

Mark Details


Serial Number

No 97310551

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 214774-9016

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.05.21 -

Triangles that are completely or partially shaded

Description of Design Search

The mark consists of the stylized wording "VAXCYTE" with an inverted triangle design positioned on top of the stylized letter "X". The colors black, grey, and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark.

Legal History


Show more

Status DateAction Taken
27th Feb 2024REGISTERED-PRINCIPAL REGISTER
27th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
23rd Jan 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Jan 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17th Jan 2024STATEMENT OF USE PROCESSING COMPLETE
12th Jan 2024TEAS STATEMENT OF USE RECEIVED
12th Jan 2024USE AMENDMENT FILED
29th Jun 2023CORRECTED NOA E-MAILED
29th Jun 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Jun 2023DIVISIONAL PROCESSING COMPLETE